
• | Revenue: $619 million |
• | Gross Margin: 67.3% GAAP (68.4% excluding special items) |
• | EPS: $0.63 GAAP ($0.72 excluding special items) |
• | Cash flow from operations: $163 million |
• | Capital expenditures: $13 million |
• | Dividends paid: $128 million ($0.48 per share) |
• | Stock repurchases: $9 million |
CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
September 26, 2020 | June 27, 2020 | September 28, 2019 | |||||||||||
(in thousands, except per share data) | |||||||||||||
Net revenues | $ | 619,357 | $ | 545,369 | $ | 533,040 | |||||||
Cost of goods sold | 202,343 | 183,001 | 189,717 | ||||||||||
Gross margin | 417,014 | 362,368 | 343,323 | ||||||||||
Operating expenses: | |||||||||||||
Research and development | 115,466 | 110,173 | 108,989 | ||||||||||
Selling, general and administrative | 82,954 | 72,893 | 76,115 | ||||||||||
Intangible asset amortization | 919 | 810 | 756 | ||||||||||
Severance and restructuring expenses | 8,813 | 678 | 1,434 | ||||||||||
Other operating expenses (income), net | 7,428 | (173 | ) | 25 | |||||||||
Total operating expenses | 215,580 | 184,381 | 187,319 | ||||||||||
Operating income | 201,434 | 177,987 | 156,004 | ||||||||||
Interest and other income (expense), net | (7,037 | ) | (8,488 | ) | 1,829 | ||||||||
Income before taxes | 194,397 | 169,499 | 157,833 | ||||||||||
Provision for (benefit from) income taxes (1)(2) | 24,883 | (37,799 | ) | 17,677 | |||||||||
Net income | $ | 169,514 | $ | 207,298 | $ | 140,156 | |||||||
Earnings per share: | |||||||||||||
Basic | $ | 0.64 | $ | 0.78 | $ | 0.52 | |||||||
Diluted | $ | 0.63 | $ | 0.77 | $ | 0.51 | |||||||
Shares used in the calculation of earnings per share: | |||||||||||||
Basic | 266,831 | 266,639 | 271,388 | ||||||||||
Diluted | 269,529 | 268,777 | 274,436 | ||||||||||
Dividends paid per share | $ | 0.48 | $ | 0.48 | $ | 0.48 | |||||||
SCHEDULE OF SPECIAL ITEMS | |||||||||||||
(Unaudited) | |||||||||||||
Three Months Ended | |||||||||||||
September 26, 2020 | June 27, 2020 | September 28, 2019 | |||||||||||
(in thousands) | |||||||||||||
Cost of goods sold: | |||||||||||||
Intangible asset amortization | $ | 4,363 | $ | 3,528 | $ | 3,111 | |||||||
Merger related expenses (3) | 1,335 | — | — | ||||||||||
Cost of COVID-19 response programs | 938 | 1,591 | — | ||||||||||
Total | $ | 6,636 | $ | 5,119 | $ | 3,111 | |||||||
Operating expenses: | |||||||||||||
Merger related expenses (3) | $ | 6,607 | $ | — | $ | — | |||||||
Intangible asset amortization | 918 | 810 | 756 | ||||||||||
Severance and restructuring | 8,813 | 678 | 1,434 | ||||||||||
Other operating expenses (income), net (3) | 7,428 | (173 | ) | 25 | |||||||||
Total | $ | 23,766 | $ | 1,315 | $ | 2,215 | |||||||
Interest and other expense (income), net | $ | (535 | ) | $ | 1,484 | $ | 207 | ||||||
Total | $ | (535 | ) | $ | 1,484 | $ | 207 | ||||||
Provision for (benefit from) for income taxes: | |||||||||||||
Impact of U.S. tax legislation (1) | $ | — | $ | 6,486 | $ | — | |||||||
Impact of income tax audit settlements (2) | — | (51,197 | ) | — | |||||||||
Total | $ | — | $ | (44,711 | ) | $ | — | ||||||
(1) Includes effect of U.S. tax legislation enacted on December 22, 2017. | |||||||||||||
(2) Includes effect of income tax audit settlements. | |||||||||||||
(3) Includes ADI merger related expenses such as accelerated stock-based compensation expense resulting from the acceleration of certain RSAs for tax withholding purposes, as well as other legal and professional services. | |||||||||||||
CONSOLIDATED BALANCE SHEETS | |||||||||||||
(Unaudited) | |||||||||||||
September 26, 2020 | June 27, 2020 | September 28, 2019 | |||||||||||
(in thousands) | |||||||||||||
ASSETS | |||||||||||||
Current assets: | |||||||||||||
Cash and cash equivalents | $ | 1,595,089 | $ | 1,578,670 | $ | 1,695,191 | |||||||
Short-term investments | 17,022 | 35,536 | 98,176 | ||||||||||
Total cash, cash equivalents and short-term investments | 1,612,111 | 1,614,206 | 1,793,367 | ||||||||||
Accounts receivable, net | 449,376 | 404,778 | 370,316 | ||||||||||
Inventories | 265,664 | 259,626 | 235,959 | ||||||||||
Other current assets | 29,816 | 39,219 | 24,982 | ||||||||||
Total current assets | 2,356,967 | 2,317,829 | 2,424,624 | ||||||||||
Property, plant and equipment, net | 542,421 | 550,406 | 574,097 | ||||||||||
Intangible assets, net | 82,679 | 87,959 | 52,376 | ||||||||||
Goodwill | 562,540 | 562,540 | 532,251 | ||||||||||
Other assets | 108,920 | 110,569 | 97,439 | ||||||||||
TOTAL ASSETS | $ | 3,653,527 | $ | 3,629,303 | $ | 3,680,787 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||
Current liabilities: | |||||||||||||
Accounts payable | $ | 86,831 | $ | 91,982 | $ | 81,794 | |||||||
Price adjustment and other revenue reserves | 144,255 | 148,916 | 90,206 | ||||||||||
Income taxes payable | 53,655 | 43,457 | 31,704 | ||||||||||
Accrued salary and related expenses | 115,460 | 126,751 | 96,168 | ||||||||||
Accrued expenses | 46,119 | 42,228 | 42,644 | ||||||||||
Total current liabilities | 446,320 | 453,334 | 342,516 | ||||||||||
Long-term debt | 994,381 | 994,022 | 992,944 | ||||||||||
Income taxes payable | 360,164 | 385,072 | 446,138 | ||||||||||
Other liabilities | 141,643 | 139,418 | 117,903 | ||||||||||
Total liabilities | 1,942,508 | 1,971,846 | 1,899,501 | ||||||||||
Stockholders' equity: | |||||||||||||
Common stock and capital in excess of par value | 12,461 | 266 | 271 | ||||||||||
Retained earnings | 1,713,153 | 1,671,786 | 1,793,012 | ||||||||||
Accumulated other comprehensive loss | (14,595 | ) | (14,595 | ) | (11,997 | ) | |||||||
Total stockholders' equity | 1,711,019 | 1,657,457 | 1,781,286 | ||||||||||
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY | $ | 3,653,527 | $ | 3,629,303 | $ | 3,680,787 | |||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||
(Unaudited) | |||||||||||||
Three months ended | |||||||||||||
September 26, 2020 | June 27, 2020 | September 28, 2019 | |||||||||||
(in thousands, except per share data) | |||||||||||||
Cash flows from operating activities: | |||||||||||||
Net income | $ | 169,514 | $ | 207,298 | $ | 140,156 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||
Stock-based compensation | 35,730 | 23,290 | 24,671 | ||||||||||
Depreciation and amortization | 24,199 | 36,384 | 23,921 | ||||||||||
Deferred taxes | (1,103 | ) | 14,386 | 453 | |||||||||
Loss from sale of property, plant and equipment | 63 | 557 | 376 | ||||||||||
Other Adjustments | 1,867 | 2,127 | 27 | ||||||||||
Changes in assets and liabilities: | |||||||||||||
Accounts receivable | (44,798 | ) | (24,078 | ) | (10,300 | ) | |||||||
Inventories | (5,986 | ) | (34,562 | ) | 10,578 | ||||||||
Other assets | 4,159 | (25,769 | ) | (52,443 | ) | ||||||||
Accounts payable | (3,423 | ) | 5,405 | 1,242 | |||||||||
Price adjustment and other revenue reserves | (4,461 | ) | 37,681 | (10,284 | ) | ||||||||
Income taxes payable | (14,710 | ) | (45,855 | ) | (25,341 | ) | |||||||
All other accrued liabilities | 1,460 | 15,465 | 38,214 | ||||||||||
Net cash provided by operating activities | 162,511 | 212,329 | 141,270 | ||||||||||
Cash flows from investing activities: | |||||||||||||
Purchases of property, plant and equipment | (12,728 | ) | (15,680 | ) | (20,631 | ) | |||||||
Proceeds from sales of property, plant and equipment | 4 | 124 | 43 | ||||||||||
Proceeds from sales of available-for-sale securities | — | 1,290 | — | ||||||||||
Proceeds from maturity of available-for-sale securities | 18,425 | 10,734 | 42,921 | ||||||||||
Payment in connection with business acquisition, net of cash acquired | — | (69,270 | ) | — | |||||||||
Purchases of investments in privately-held companies | (84 | ) | (1,840 | ) | — | ||||||||
Proceeds from sale of investments in privately-held companies | 25 | 205 | 516 | ||||||||||
Other investing activities | — | 2 | (35 | ) | |||||||||
Net cash provided by (used in) investing activities | 5,642 | (74,435 | ) | 22,814 | |||||||||
Cash flows from financing activities: | |||||||||||||
Net issuance of restricted stock units and awards | (17,018 | ) | (6,741 | ) | (9,943 | ) | |||||||
Proceeds from stock options exercised | 2,632 | 2,240 | 7,482 | ||||||||||
Issuance of common stock under employee stock purchase program | — | 23,725 | — | ||||||||||
Repurchase of common stock | (9,201 | ) | (82,299 | ) | (93,552 | ) | |||||||
Dividends paid | (128,147 | ) | (128,058 | ) | (130,222 | ) | |||||||
Net cash used in financing activities | (151,734 | ) | (191,133 | ) | (226,235 | ) | |||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | 16,419 | (53,239 | ) | (62,151 | ) | ||||||||
Cash, cash equivalents and restricted cash | |||||||||||||
Beginning of period | $ | 1,585,428 | $ | 1,638,667 | $ | 1,757,342 | |||||||
End of period | $ | 1,601,847 | $ | 1,585,428 | $ | 1,695,191 | |||||||
Total cash, cash equivalents, and short-term investments | $ | 1,612,111 | $ | 1,614,206 | $ | 1,793,367 | |||||||
Cash, cash equivalents and restricted cash: | |||||||||||||
Cash and cash equivalents | $ | 1,595,089 | $ | 1,578,670 | $ | 1,695,191 | |||||||
Restricted cash in Other assets | 6,758 | 6,758 | — | ||||||||||
Total cash, cash equivalents and restricted cash | $ | 1,601,847 | $ | 1,585,428 | $ | 1,695,191 | |||||||
ANALYSIS OF GAAP VERSUS GAAP EXCLUDING SPECIAL ITEMS DISCLOSURES | ||||||||||||||
(Unaudited) | ||||||||||||||
Three Months Ended | ||||||||||||||
September 26, 2020 | June 27, 2020 | September 28, 2019 | ||||||||||||
(in thousands, except per share data) | ||||||||||||||
Reconciliation of GAAP gross profit to GAAP gross profit excluding special items: | ||||||||||||||
GAAP gross profit | $ | 417,014 | $ | 362,368 | $ | 343,323 | ||||||||
GAAP gross profit % | 67.3 | % | 66.4 | % | 64.4 | % | ||||||||
Special items: | ||||||||||||||
Intangible asset amortization | 4,363 | 3,528 | 3,111 | |||||||||||
Merger related expenses (1) | 1,335 | — | — | |||||||||||
Cost of COVID-19 response programs | 938 | 1,591 | — | |||||||||||
Total special items | 6,636 | 5,119 | 3,111 | |||||||||||
GAAP gross profit excluding special items | $ | 423,650 | $ | 367,487 | $ | 346,434 | ||||||||
GAAP gross profit % excluding special items | 68.4 | % | 67.4 | % | 65.0 | % | ||||||||
Reconciliation of GAAP operating expenses to GAAP operating expenses excluding special items: | ||||||||||||||
GAAP operating expenses | $ | 215,580 | $ | 184,381 | $ | 187,319 | ||||||||
Special items: | ||||||||||||||
Merger related expenses (1) | 6,607 | — | — | |||||||||||
Intangible asset amortization | 918 | 810 | 756 | |||||||||||
Severance and restructuring | 8,813 | 678 | 1,434 | |||||||||||
Other operating expenses (income), net (1) | 7,428 | (173 | ) | 25 | ||||||||||
Total special items | 23,766 | 1,315 | 2,215 | — | ||||||||||
GAAP operating expenses excluding special items | $ | 191,814 | $ | 183,066 | $ | 185,104 | ||||||||
Reconciliation of GAAP net income to GAAP net income excluding special items: | ||||||||||||||
GAAP net income | $ | 169,514 | $ | 207,298 | $ | 140,156 | ||||||||
Special items: | ||||||||||||||
Intangible asset amortization | 5,281 | 4,338 | 3,867 | |||||||||||
Merger related expenses (1) | 7,942 | — | — | |||||||||||
Cost of COVID-19 response programs | 938 | 1,591 | — | |||||||||||
Severance and restructuring | 8,813 | 678 | 1,434 | |||||||||||
Other operating expenses (income), net (1) | 7,428 | (173 | ) | 25 | ||||||||||
Interest and other expense (income), net | (535 | ) | 1,484 | (207 | ) | |||||||||
Pre-tax total special items | 29,867 | 7,918 | 5,119 | |||||||||||
Other income tax effects and adjustments (2) | (4,272 | ) | (14,378 | ) | (3,506 | ) | ||||||||
Impact of U.S. tax legislation (3) | — | 6,486 | — | |||||||||||
Impact of income tax audit settlements (4) | — | (51,197 | ) | — | ||||||||||
GAAP net income excluding special items | $ | 195,109 | $ | 156,127 | $ | 141,769 | ||||||||
GAAP net income per share excluding special items: | ||||||||||||||
Basic | $ | 0.73 | $ | 0.59 | $ | 0.52 | ||||||||
Diluted | $ | 0.72 | $ | 0.58 | $ | 0.52 | ||||||||
Shares used in the calculation of earnings per share excluding special items: | ||||||||||||||
Basic | 266,831 | 266,639 | 271,388 | |||||||||||
Diluted | 269,529 | 268,777 | 274,436 | |||||||||||
(1) Includes ADI merger related expenses such as accelerated stock-based compensation expense resulting from the acceleration of certain RSAs for tax withholding purposes, as well as other legal and professional services. | ||||||||||||||
(2) Includes tax effect of pre-tax special items and miscellaneous tax adjustments. | ||||||||||||||
(3) Includes effect of U.S. tax legislation enacted on December 22, 2017. | ||||||||||||||
(4) Includes effect of income tax audit settlements. | ||||||||||||||